The story of Sildenafil presents a nuanced case for investors in the medicinal sector. While initially a tremendous success, creating vast sums, the intellectual property end and the subsequent entry of off-brand https://adult392871.blogolenta.com/38818056/viagra-and-pharma-a-risky-play